Two threads dominate the GLP1Forum experimental parameter conversation: "Picking my first Tirz dose" and "Restarting Tirz after a break." Combined, they capture the core anxiety of every GLP-1 researcher — am I applying the wrong experimental parameter, or has the compound stopped working?
The 5-Day Tirzepatide Protocol: Community Consensus
Tirzepatide's half-life is 5 days. The standard 7-day interval means days 5-7 operate at trough plasma concentration — and roughly 50% of researchers report a "last two days appetite signaling rebound" during this window. The 5-day protocol eliminates the trough: same test parameter, every 5 days instead of every 7. The trade-off is straightforward: ~40% higher monthly consumption (six applications per month versus four). For researchers with adequate supply and budget, the 5-day protocol provides the smoothest pharmacokinetic curve.
Retatrutide operates differently. Its 6-day half-life makes the 7-day interval appropriate — extending to 10 days reliably triggers appetite signaling rebound. Do not apply Tirzepatide experimental parameter logic to Retatrutide; their GCGR/GIPR activity profiles are pharmacokinetically distinct.
When to Switch vs. When to Co-Apply
A true plateau is not a bad week — it is four consecutive weeks averaging less than 0.5 lb/week loss on a 7-day moving average. Daily scale readings are unreliable (±2 lbs from water fluctuation alone). Calculate your 7-day rolling average; only act on the trend line.
- Tirzepatide diminishing: Escalated from 10 mg to 15 mg with no effect? Consider switching to Retatrutide. Stop Tirzepatide for 7 days, then initiate Reta at 2 mg.
- Retatrutide diminishing: Capped at 12 mg with sustained plateau? Add Cagrilintide (amylin analog) or CJC-1295/Ipamorelin as a co-applied protocol rather than escalating Reta further. The triple-agonist mechanism is already near-maximal at 12 mg; the marginal return on test parameter escalation beyond this point is low.
Ourovia recommendation: Track a 7-day rolling average of total mass before declaring a plateau. Most "plateaus" reported in the community are normal weekly fluctuations. True plateaus — four consecutive weeks of flat trend — require a protocol change. Do not escalate test parameters based on a single week's data; you will overshoot and accumulate secondary observations for no additional benefit.
